Targeting NMDA Receptor Complex in Management of Epilepsy
<i>N</i>-methyl-D-aspartate receptors (NMDARs) are widely distributed in the central nervous system (CNS) and play critical roles in neuronal excitability in the CNS. Both clinical and preclinical studies have revealed that the abnormal expression or function of these receptors can under...
Main Authors: | Shravan Sivakumar, Mehdi Ghasemi, Steven C. Schachter |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/15/10/1297 |
Similar Items
-
NMDA receptor antagonists as potential therapy in cerebellar degenerative disorders
by: Olga S. Belozor, et al.
Published: (2022-06-01) -
Treatment of Cerebral Ischemia Through NMDA Receptors: Metabotropic Signaling and Future Directions
by: Yuanyuan Li, et al.
Published: (2022-02-01) -
Current Evidence of Chinese Herbal Constituents with Effects on NMDA Receptor Blockade
by: David T. Yew, et al.
Published: (2013-08-01) -
Anesthetic care for patients with anti-NMDA receptor encephalitis
by: Faris Al Ghamdi, et al.
Published: (2020-01-01) -
Oscillations and NMDA Receptors: Their Interplay Create Memories
by: Chris Cadonic, et al.
Published: (2014-06-01)